PriceTargets.com logo

Couchbase - BASE Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $21.41
  • Forecasted Upside: 25.14%
  • Number of Analysts: 17
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 14 Buy Ratings
  • 0 Strong Buy Ratings
$17.11 As of 04/29/2025 05:00 PM ET
▼ -0.03 (-0.18%)

This chart shows the closing price for BASE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Couchbase Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BASE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BASE

Analyst Price Target is $21.41
▲ +25.14% Upside Potential
This price target is based on 17 analysts offering 12 month price targets for Couchbase in the last 3 months. The average price target is $21.41, with a high forecast of $26.00 and a low forecast of $16.00. The average price target represents a 25.14% upside from the last price of $17.11.

This chart shows the closing price for BASE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 17 contributing investment analysts is to moderate buy stock in Couchbase. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
11/6/2023
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
2/4/2024
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
5/4/2024
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
8/2/2024
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
10/31/2024
  • 0 strong buy ratings
  • 13 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
1/29/2025
  • 0 strong buy ratings
  • 13 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
3/30/2025
  • 0 strong buy ratings
  • 14 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
4/29/2025

Latest Recommendations

  • 0 strong buy ratings
  • 14 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/23/2025Piper SandlerLower TargetOverweight ➝ Overweight$22.00 ➝ $16.00
4/16/2025Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$23.00 ➝ $18.00
4/9/2025Rosenblatt SecuritiesInitiated CoverageBuy$20.00
2/27/2025The Goldman Sachs GroupLower TargetSell ➝ Sell$18.00 ➝ $16.00
2/26/2025UBS GroupLower TargetNeutral ➝ Neutral$19.00 ➝ $18.00
2/26/2025Royal Bank of CanadaLower TargetOutperform ➝ Outperform$25.00 ➝ $22.00
2/26/2025GuggenheimLower TargetBuy ➝ Buy$30.00 ➝ $26.00
2/26/2025Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$25.00 ➝ $23.00
2/26/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$23.00 ➝ $20.00
2/26/2025BarclaysLower TargetOverweight ➝ Overweight$23.00 ➝ $22.00
2/26/2025Piper SandlerBoost TargetOverweight ➝ Overweight$21.00 ➝ $22.00
2/26/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$22.00 ➝ $22.00
12/12/2024Truist FinancialInitiated CoverageBuy$21.00
12/4/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$25.00 ➝ $25.00
12/4/2024DA DavidsonReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00
12/4/2024GuggenheimReiterated RatingBuy ➝ Buy$30.00 ➝ $30.00
12/4/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$27.00 ➝ $25.00
12/4/2024Stifel NicolausBoost TargetBuy ➝ Buy$20.00 ➝ $22.00
12/4/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$21.00 ➝ $21.00
12/4/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$22.00 ➝ $22.00
12/4/2024Robert W. BairdLower TargetOutperform ➝ Outperform$27.00 ➝ $25.00
11/15/2024BarclaysBoost TargetOverweight ➝ Overweight$19.00 ➝ $23.00
10/17/2024WedbushInitiated CoverageOutperform$26.00
10/7/2024BarclaysUpgradeEqual Weight ➝ Overweight$19.00 ➝ $19.00
9/5/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$25.00 ➝ $25.00
9/5/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$30.00 ➝ $23.00
9/5/2024OppenheimerLower TargetOutperform ➝ Outperform$25.00 ➝ $23.00
9/5/2024DA DavidsonLower TargetBuy ➝ Buy$30.00 ➝ $25.00
9/5/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$20.00 ➝ $19.00
9/5/2024UBS GroupLower TargetNeutral ➝ Neutral$24.00 ➝ $19.00
9/5/2024Stifel NicolausLower TargetBuy ➝ Buy$25.00 ➝ $20.00
9/5/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$29.00 ➝ $27.00
9/5/2024Piper SandlerLower TargetOverweight ➝ Overweight$22.00 ➝ $21.00
9/5/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$22.00 ➝ $22.00
9/5/2024Robert W. BairdLower TargetOutperform ➝ Outperform$32.00 ➝ $27.00
8/19/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$27.00 ➝ $20.00
8/16/2024Piper SandlerInitiated CoverageOverweight$22.00
8/16/2024Piper Sandler CompaniesInitiated CoverageOverweight$22.00
6/26/2024Needham & Company LLCInitiated CoverageBuy$22.00
6/25/2024GuggenheimReiterated RatingBuy ➝ Buy$30.00 ➝ $30.00
6/7/2024DA DavidsonLower TargetBuy ➝ Buy$35.00 ➝ $30.00
6/6/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$37.00 ➝ $30.00
6/6/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$33.00 ➝ $27.00
6/6/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$30.00 ➝ $29.00
6/6/2024OppenheimerLower TargetOutperform ➝ Outperform$36.00 ➝ $30.00
6/6/2024Royal Bank of CanadaLower TargetOutperform ➝ Outperform$35.00 ➝ $31.00
6/6/2024Robert W. BairdLower TargetOutperform ➝ Outperform$35.00 ➝ $32.00
6/6/2024The Goldman Sachs GroupDowngradeNeutral ➝ Sell$30.00 ➝ $18.00
5/22/2024UBS GroupInitiated CoverageNeutral$31.00
3/7/2024The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$20.00 ➝ $30.00
3/6/2024DA DavidsonBoost TargetBuy ➝ Buy$27.00 ➝ $35.00
3/6/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$32.00 ➝ $35.00
3/6/2024OppenheimerBoost TargetOutperform ➝ Outperform$25.00 ➝ $36.00
3/6/2024Stifel NicolausBoost TargetBuy ➝ Buy$24.00 ➝ $33.00
3/6/2024GuggenheimBoost TargetBuy ➝ Buy$27.00 ➝ $32.00
3/6/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$29.00 ➝ $33.00
3/6/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$28.00 ➝ $35.00
3/5/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$26.00 ➝ $34.00
2/20/2024BarclaysDowngradeOverweight ➝ Equal Weight$26.00 ➝ $29.00
1/12/2024BarclaysBoost TargetOverweight ➝ Overweight$23.00 ➝ $26.00
1/8/2024Wells Fargo & CompanyInitiated CoverageOverweight$26.00
12/14/2023OppenheimerBoost TargetOutperform$23.00 ➝ $25.00
12/14/2023Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$26.00
12/11/2023BarclaysBoost TargetOverweight ➝ Overweight$21.00 ➝ $23.00
12/7/2023Stifel NicolausBoost TargetBuy ➝ Buy$22.00 ➝ $24.00
12/7/2023Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$25.00 ➝ $26.00
12/7/2023OppenheimerBoost TargetOutperform$23.00 ➝ $25.00
12/7/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$20.00 ➝ $21.00
9/13/2023Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$25.00
9/7/2023William BlairReiterated RatingOutperform
9/7/2023Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$25.00
8/18/2023BarclaysLower TargetOverweight ➝ Overweight$23.00 ➝ $20.00
6/7/2023DA DavidsonBoost Target$22.00 ➝ $24.00
6/7/2023Stifel NicolausBoost Target$19.00 ➝ $22.00
6/7/2023Robert W. BairdBoost Target$20.00 ➝ $23.00
6/7/2023BarclaysBoost Target$19.00 ➝ $23.00
6/5/2023Royal Bank of CanadaBoost Target$20.00 ➝ $25.00
3/8/2023GuggenheimReiterated RatingBuy$20.00
3/8/2023Stifel NicolausBoost TargetBuy$17.00 ➝ $19.00
3/8/2023Robert W. BairdBoost TargetOutperform$18.00 ➝ $20.00
3/8/2023Royal Bank of CanadaBoost TargetOutperform$18.00 ➝ $20.00
3/8/2023Morgan StanleyBoost TargetEqual Weight$18.00 ➝ $19.00
2/15/2023BarclaysBoost TargetOverweight$16.00 ➝ $19.00
1/26/2023GuggenheimInitiated CoverageBuy$20.00
1/10/2023BarclaysLower TargetOverweight$18.00 ➝ $16.00
12/14/2022WedbushInitiated CoverageNeutral$16.00
12/7/2022The Goldman Sachs GroupLower TargetNeutral$20.00 ➝ $18.00
12/7/2022Robert W. BairdLower Target$22.00 ➝ $18.00
12/7/2022Royal Bank of CanadaLower TargetOutperform$20.00 ➝ $18.00
12/7/2022BarclaysBoost TargetOverweight$17.00 ➝ $18.00
11/21/2022Morgan StanleyLower TargetEqual Weight$19.00 ➝ $18.00
11/18/2022BarclaysLower TargetOverweight$20.00 ➝ $17.00
10/18/2022BarclaysLower TargetOverweight$22.00 ➝ $20.00
9/8/2022William BlairReiterated RatingOutperform
9/8/2022Morgan StanleyBoost TargetEqual Weight$18.00 ➝ $19.00
9/8/2022Robert W. BairdLower TargetOutperform$25.00 ➝ $22.00
9/8/2022BarclaysLower TargetOverweight$23.00 ➝ $22.00
8/16/2022BarclaysBoost TargetOverweight$19.00 ➝ $23.00
6/14/2022DA DavidsonInitiated CoverageBuy$21.00
6/10/2022Robert W. BairdLower TargetOutperform$35.00 ➝ $25.00
6/9/2022Morgan StanleyBoost TargetEqual Weight$17.00 ➝ $18.00
6/9/2022The Goldman Sachs GroupLower TargetNeutral$28.00 ➝ $25.00
6/9/2022Stifel NicolausLower Target$25.00 ➝ $20.00
6/9/2022OppenheimerLower TargetOutperform$25.00 ➝ $22.00
6/6/2022Royal Bank of CanadaLower Target$27.00 ➝ $25.00
5/20/2022BarclaysLower TargetOverweight$26.00 ➝ $19.00
5/19/2022Morgan StanleyLower TargetEqual Weight$22.00 ➝ $17.00
4/14/2022The Goldman Sachs GroupLower TargetNeutral$37.00 ➝ $28.00
3/11/2022The Goldman Sachs GroupReiterated RatingNeutral ➝ Neutral$43.00 ➝ $37.00
3/10/2022William BlairReiterated RatingOutperform
3/10/2022Royal Bank of CanadaLower TargetOutperform$29.00 ➝ $27.00
3/10/2022Morgan StanleyLower TargetEqual Weight$24.00 ➝ $22.00
3/10/2022BarclaysLower TargetOverweight$30.00 ➝ $26.00
3/10/2022Stifel NicolausLower TargetBuy$41.00 ➝ $25.00
3/10/2022Robert W. BairdLower Target$50.00 ➝ $35.00
2/23/2022Morgan StanleyLower TargetEqual Weight$37.00 ➝ $24.00
1/12/2022BarclaysLower TargetOverweight$41.00 ➝ $30.00
12/8/2021The Goldman Sachs GroupLower TargetNeutral$49.00 ➝ $42.00
12/8/2021OppenheimerLower TargetOutperform$50.00 ➝ $44.00
12/8/2021BarclaysLower TargetOverweight ➝ Overweight$52.00 ➝ $41.00
12/6/2021Royal Bank of CanadaLower TargetOutperform ➝ Outperform$53.00 ➝ $43.00
9/9/2021Morgan StanleyBoost TargetEqual Weight$34.00 ➝ $37.00
9/9/2021OppenheimerBoost TargetOutperform$40.00 ➝ $50.00
9/9/2021Robert W. BairdBoost TargetOutperform$43.00 ➝ $50.00
9/9/2021BarclaysBoost TargetOverweight$42.00 ➝ $54.00
9/7/2021Royal Bank of CanadaBoost TargetOutperform$40.00 ➝ $53.00
8/16/2021OppenheimerInitiated CoverageOutperform$40.00
8/16/2021William BlairInitiated CoverageOutperform
8/16/2021Robert W. BairdInitiated CoverageOutperform$43.00
8/16/2021Stifel NicolausInitiated CoverageBuy$43.00
8/16/2021Royal Bank of CanadaInitiated CoverageOutperform$40.00
8/16/2021Morgan StanleyInitiated CoverageEqual Weight
8/16/2021The Goldman Sachs GroupInitiated CoverageNeutral
8/16/2021BarclaysInitiated CoverageOverweight$42.00
(Data available from 4/30/2020 forward)

News Sentiment Rating

0.93 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 14 very positive mentions
  • 15 positive mentions
  • 4 negative mentions
  • 2 very negative mentions
Mentions as of
10/1/2024
  • 14 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/31/2024
  • 6 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/30/2024
  • 20 very positive mentions
  • 23 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
12/30/2024
  • 10 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/29/2025
  • 14 very positive mentions
  • 24 positive mentions
  • 7 negative mentions
  • 1 very negative mentions
Mentions as of
2/28/2025
  • 10 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
3/30/2025
  • 17 very positive mentions
  • 10 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
4/29/2025

Current Sentiment

  • 17 very positive mentions
  • 10 positive mentions
  • 4 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Couchbase logo
Couchbase, Inc. provides cloud database platform for enterprise applications in the United States and internationally. Its database works in multiple configurations, ranging from cloud to multi- or hybrid-cloud to on-premise environments to the edge. The company offers Couchbase Capella, an automated and secure Database-as-a-Service that simplifies database management by deploying, managing, and operating Couchbase Server across cloud environments; and Couchbase Server, a multi-service NoSQL database, which provides SQL-compatible query language and SQL++ that allows for a various array of data manipulation functions. It also provides Couchbase Mobile, an embedded NoSQL database for mobile and edge devices that enables an always-on experience with high data availability, even without internet connectivity, as well as synchronization gateway that allows for secure data sync between mobile devices and the backend data store. The company sells its platform through direct sales force and an ecosystem of partners. It serves governments and organizations, as well as enterprises in various industries, including retail and e-commerce, travel and hospitality, financial services and insurance, software and technology, gaming, media and entertainment, and industrials. The company was formerly known as Membase, Inc. and changed its name to Couchbase, Inc. in February 2011. Couchbase, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Read More

Today's Range

Now: $17.11
Low: $16.91
High: $17.20

50 Day Range

MA: $15.48
Low: $13.17
High: $18.26

52 Week Range

Now: $17.11
Low: $12.78
High: $28.67

Volume

399,868 shs

Average Volume

575,987 shs

Market Capitalization

$923.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.85

Frequently Asked Questions

What sell-side analysts currently cover shares of Couchbase?

The following Wall Street sell-side analysts have issued research reports on Couchbase in the last year: Barclays PLC, DA Davidson, Guggenheim, Morgan Stanley, Needham & Company LLC, Oppenheimer Holdings Inc., Piper Sandler, Piper Sandler Companies, Robert W. Baird, Rosenblatt Securities, Royal Bank of Canada, Stifel Nicolaus, The Goldman Sachs Group, Inc., Truist Financial Co., UBS Group AG, Wedbush, and Wells Fargo & Company.
View the latest analyst ratings for BASE.

What is the current price target for Couchbase?

0 Wall Street analysts have set twelve-month price targets for Couchbase in the last year. Their average twelve-month price target is $21.41, suggesting a possible upside of 25.1%. Wedbush has the highest price target set, predicting BASE will reach $26.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $16.00 for Couchbase in the next year.
View the latest price targets for BASE.

What is the current consensus analyst rating for Couchbase?

Couchbase currently has 1 sell rating, 2 hold ratings and 14 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for BASE.

What other companies compete with Couchbase?

Other companies that are similar to Couchbase include Rumble, Pony AI, Clear Secure, Braze and AvePoint. Learn More about companies similar to Couchbase.

How do I contact Couchbase's investor relations team?

The company's listed phone number is 650-417-7500 and its investor relations email address is [email protected]. The official website for Couchbase is www.couchbase.com. Learn More about contacing Couchbase investor relations.